innoscripta Logo Whiteinnoscripta Logo Blue
innoscripta Logo

Blog & Media

Ideas & Updates from innoscripta

Explore stories, insights, and innovations from the people building the future of R&D and digital tax technology.

Mar 06, 2026

Global Expansion at innoscripta Leveraging R&D

Feb 16, 2026

DER AKTIONÄR interviews COO Sebastian Schwertlein on Clusterix and international expansion

Dec 23, 2025

GoingPublic Magazine: innoscripta digitises process management for R&D

Dec 05, 2025

Research allowance 2026 - the most important changes at a glance

Dec 08, 2025

Markt & Mittelstand reports: How innoscripta automates R&D tax documentation

Dec 03, 2025

Börsenradio interview: innoscripta on growth, data infrastructure and Q3 results

Nov 19, 2025

NebenwerteWelt podcast: innoscripta – Rethinking R&D management

Nov 12, 2025

Forschungszulage for software development: Overcoming common application pitfalls

Nov 04, 2025

Strong growth and impressive results: Börsengeflüster on Innoscripta SE

Global Expansion at innoscripta Leveraging R&D

Mar 06, 2026

Global Expansion at innoscripta Leveraging R&D

Take advantage of tax credits and IP BOX in the United States and France with us!

DER AKTIONÄR interviews COO Sebastian Schwertlein on Clusterix and international expansion

Feb 13, 2026

DER AKTIONÄR interviews COO Sebastian Schwertlein on Clusterix and international expansion

DER AKTIONÄR features an interview with COO Sebastian Schwertlein on innoscripta’s development since the IPO, the technological positioning of the all-in-one platform Clusterix and the company’s expansion plans in Germany and across Europe. The discussion highlights platform differentiation, integrated R&D process tools and strategic growth priorities for the coming years.Know more: https://www.deraktionaer.de/artikel/aktien/innoscripta-coo-sebastian-schwertlein-ueber-den-boersengang-clusterix-und-expansionsplaene-20395466.html

GoingPublic Magazine: innoscripta digitises process management for R&D

Dec 23, 2025

GoingPublic Magazine: innoscripta digitises process management for R&D

GoingPublic Magazine presents innoscripta as a software provider for structured process and data management in research and development. The article explains how the platform consolidates data from multiple enterprise systems, automates documentation workflows and enables scalability, transparency and profitability. An interview with COO Sebastian Schwertlein offers additional insights into growth, international expansion and product strategy.Read more: The full article is available in the GoingPublic Magazine 04/2025 e-paper on pages 64–65.Article link: https://www.goingpublic.de/wp-content/uploads/epaper/epaper-GoingPublic_04-2025/?mc_cid=86a304b27b&mc_eid=2903c93db2#0

Research allowance 2026 - the most important changes at a glance

Dec 05, 2025

Research allowance 2026 - the most important changes at a glance

Significant improvements to the tax credit for research and development will come into effect on January 1, 2026. The "Act for an Immediate Tax Investment Program to Strengthen Germany as a Business Location" will make the funding even more attractive.Here you can find out what exactly is changing – and how you can benefit.Maximum assessment basisFrom 2026, the maximum annual assessment base will increase from €10 million to €12 million, thus enabling significantly greater tax relief. Small and medium-sized enterprises (SMEs) will therefore be eligible for up to €4.2 million in annual funding, while larger companies will receive up to €3 million.Overhead flat rateIn addition to the direct project costs, consisting of personnel costs for R&D staff and, where applicable, co-entrepreneurs, 70% of the contract costs for R&D services within the EEA, and depreciation of capital goods, a flat rate of 20% of the direct costs is recognized as eligible overhead and operating costs. This means that for projects starting in 2026 or later, the basis for calculating the research allowance increases by 20%.DepreciationDepreciation on movable assets is eligible for higher amounts under the new provisions for declining-balance depreciation (§7 German Income Tax Act), provided that these assets are used for business purposes and are necessary for the R&D project. This regulation initially applies to movable fixed assets acquired or manufactured between June 30, 2025, and January 1, 2028.Own contributionThe eligible hourly rate for in-house R&D services provided by co-entrepreneurs or sole proprietors will increase from a maximum of 70 euros to a maximum of 100 euros per hour for a maximum of 40 hours per week starting in 2026.Comparison of currently relevant funding periods

Markt & Mittelstand reports: How innoscripta automates R&D tax documentation

Dec 03, 2025

Markt & Mittelstand reports: How innoscripta automates R&D tax documentation

Markt & Mittelstand outlines how innoscripta automates R&D tax documentation and unlocks significant efficiency gains for companies. The article explains how the platform aggregates data from numerous internal tools, reduces administrative workload and delivers compliant, audit-proof documentation. It also highlights the company’s rapid growth, its upcoming expansion into the U.S. market and a performance-driven business model that differentiates innoscripta from major consulting firms.Read more: https://www.marktundmittelstand.de/technologie/innoscripta

Börsenradio interview: innoscripta on growth, data infrastructure and Q3 results

Dec 02, 2025

Börsenradio interview: innoscripta on growth, data infrastructure and Q3 results

At the Deutsche Börse Equity Forum, Börsenradio interviewed Max Hunger and Johanna-Luise Pontani about innoscripta’s strong Q3 performance, its data-driven approach to funding processes and the scalability of the Clusterix platform. The full interview is now available.Listen to the full episode:https://www.brn-ag.de/45020-innoscripta-Q2-2025-EKF-

NebenwerteWelt podcast: innoscripta – Rethinking R&D management

Nov 19, 2025

NebenwerteWelt podcast: innoscripta – Rethinking R&D management

The NebenwerteWelt podcast features Sebastian Schwertlein, COO of innoscripta SE, discussing the digital transformation of R&D funding processes and the impact of the Clusterix platform. The episode highlights how companies can manage and document innovation projects more efficiently, innoscripta’s development following the IPO, and why the company is gaining attention among tech-focused investors.Listen to the full episode: https://nebenwertewelt.podigee.io/28-innoscripta

Forschungszulage for software development: Overcoming common application pitfalls

Nov 12, 2025

Forschungszulage for software development: Overcoming common application pitfalls

Germany is globally known as a high-tech hub with an increasing amount of innovation, building transformative solutions and disruptive software development. The advancements of software solutions in verticals like artificial intelligence, blockchain, internet of things (IoT), robotics, and augmented reality are deeply aligned with the country's technological leadership. Companies across industries employ software tools to enhance productivity and competitive advantage. Fields like biometrics, aviation, drone technology, embedded systems, and industry 4.0 are a few examples where software helps streamline work processes.Significant innovation in the industry of software development in Germany could be seen in fields such as generative AI integration, cloud-native architectures, and growing start-up ecosystems. The Research Allowance Act (Forschungszulagengesetz - FZulG) was introduced by the German government recognising these advancements and the continued focus on research and innovation in software development among other areas. The main objective of the Forschungszulage initiative is to financially support organisations that invest in R&D and companies receive monetary assistance in form of tax credits, which reduces the amount of tax payable. If the company does not have a tax liability, then it will receive direct cash refunds based on its eligible R&D project expenditure. For the software development industry, in spite of having promising work, the projects frequently fall short while claiming research allowance. Deeply understanding the elements contributing to success and failure of a Forschungszulage application helps companies to navigate effectively through the process and obtain the support they deserve for their innovative software project. What type of software development projects qualify for the Research Allowance?To be eligible for the research allowance in Germany, software development projects must be classified as R&D work. The research project should match the Frascati Criteria which outline the characteristics of an R&D work and also the guidelines from the BSFZ that validate the project for the research allowance. The qualifying research activities are mainly divided into three categories:1. Basic ResearchThese research activities are primarily undertaken to obtain new knowledge without having any immediate practical and direct commercial application. In software development, this could include:Development of new algorithms in theoretical computer scienceDeveloping brand-new principles for programming languagesCreating new ways for developing software 2. Industrial ResearchResearch projects conducted to acquire new knowledge and expertise either to develop new products, services or processes or to significantly improve the existing products, services or processes are considered as industrial research. It involves projects such as:Developing software tools for specialised application like e.g. image processingDesigning innovative programming languagesDeveloping new data management systems3. Experimental developmentExperimental development projects use and combine existing knowledge to develop a new product, service or process. Activities related to formation, planning, and documentation of new products are considered as experimental development. In the software development field, this includes:Creating experimental AI or machine learning modelsPrototyping new software architectureDeveloping new data processing pipelinesProjects that adhere to these criteria and have technical uncertainty and development risks are considered as strong candidates for the research allowance. Why are software development projects frequently rejected?Despite pre-defined eligibility guidelines, software development projects are frequently being rejected for research allowance. Several reasons leading to this include:Vague definition of innovationThe BSFZ requires applicants to define the innovation process, including the problems and uncertainties addressed precisely. Many applications fail because they merely focus on describing the final product without providing enough information showing new scientific or technical knowledge. Due to the absence of a detailed narrative regarding the technical challenges, the newness, and the risks, the application often fails to succeed.High emphasis on implementationA usual pitfall for software development projects is presenting the ones that emphasize the implementation of existing solutions. Routine activities like adapting existing software and integrating known libraries do not qualify as R&D, and the research allowance only considers a project that is innovative and bridges a knowledge gap.Insufficient technical informationAn application prepared with superficial project descriptions which lack the required technical details will lead to rejection. Applications need to convey the technical complexity of the R&D activities. For a software project, involvement of the lead developer or software engineer is essential to ensure optimum project description, as they can explain the technical complexities and innovative elements of the project.How to handle inquiries and rejectionsAn application being questioned or rejected does not necessarily indicate the end of the road in seeking research allowance. There are options available for applicants:1. Responding to additional information requestThe BSFZ seeks additional information regarding the project if the submitted information does not provide complete clarity. This is not a rejection, but the request to submit further accurate information to continue verifying the project to issue the certificate. 2. Filing an appeal Applicants can file an appeal within a month after receiving a rejection if they find that the application was wrongfully rejected due to misunderstanding or mistakes in assessment. The appeal should provide clear information supporting the eligibility of the project and not merely on questioning the decision. Applicants should analyse the given reasons for the rejection, compare the application with the relevant guidelines and provide a well-structured appeal with proofs supporting the claim. 3. Submit a new applicationWhen the application is rejected due to a poor structure or wrong information, then it is best to submit a revised, well-prepared application. The new application should include:A clear description addressing technical complexities of the projectCorrections on previously identified weaknessesConclusionObtaining research allowance for software development projects in Germany requires focused preparation and a strong understanding of the eligibility criteria and related guidelines. Detailed documentation of technical innovation, active involvement of the software engineer or lead developer in drafting the application, and providing precise technical narratives can help the software project to be successful while seeking research allowance. In the cases of rejection, strategic approaches like understanding the causes of rejection, filing an appeal, or submitting a new application can lead to eventual success. With the right approach, Germany's Forschungszulage is a valuable opportunity for software development projects to scale up innovation.

Strong growth and impressive results: Börsengeflüster on Innoscripta SE

Nov 03, 2025

Strong growth and impressive results: Börsengeflüster on Innoscripta SE

The financial platform Börsengeflüster highlights innoscripta SE’s exceptionally strong performance in its latest analysis. With revenue growth of more than 80 percent and an EBIT margin close to 58 percent, the company ranks among the most profitable in the Scale segment. The report emphasizes the importance of upcoming capital market conferences for innoscripta’s continued expansion.Read more: https://publisher.boersengefluester.de/de/innoscripta-ungewohnliche-renditen

Ready to Take the Next Step?

Our experts can help you assess your eligibility, structure your R&D documentation, and maximize the benefits of the Research Allowance.

innoscripta Logo White

We pioneer global R&D software solutions.



Copyright © 2026 - innoscripta SE

innoscripta SE, Arnulfstraße 60, 80335 München

+49 (0) 89 255553537

info@innoscripta.com